Praxis Precision Medicines, Inc.
PRAX
$250.33
-$2.92-1.15%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/8/2026
-
MarketBeat
6/9/2026
-
TipRanks
6/8/2026
-
SeekingAlpha
6/8/2026
-
Seeking Alpha: Transcripts
6/6/2026
-
Simply Wall St
6/5/2026
-
Yahoo! Finance: News
6/5/2026
-
Tickeron - Stocks
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
6/4/2026
-
Globe Newswire
6/4/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/3/2026
-
MarketBeat
6/3/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
6/3/2026
-
Tickeron - Stocks
6/2/2026
-
TipRanks Financial Blog
6/2/2026
-
Globe Newswire
6/2/2026
-
Zero Hedge
6/2/2026
-
Benzinga
6/2/2026
-
FierceBiotech.com - Biotech
6/1/2026
-
TipRanks Financial Blog
6/1/2026
-
Globe Newswire
6/1/2026
-
Simply Wall St
6/1/2026
-
TipRanks Financial Blog
5/29/2026
-
TipRanks Financial Blog
5/29/2026
-
Insider Monkey
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 300 8460
Address
99 High Street
Boston, MA 02110
Boston, MA 02110
Country
Year Founded
Business Description
Sector
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal...
more